CEROW
CERO THERAPEUTICS HOLDINGS, INC.
OTC Biological Products, (No Diagnostic Substances)
Emerging growth company

Key Financials

Net Income
$-19920262
↓ 157.6%
Operating Income
$-15300903
↓ 1605.5%
Total Assets
$3.6M
↓ 41.3%
EPS (Diluted)
$-18.15
↑ 81.5%
Total Liabilities
$9.1M
↑ 12.2%
Shareholders' Equity
$-5446462.00
↓ 187.5%
Long-term Debt
$136765.00
N/A
Cash & Equivalents
$96873.00
↓ 79.6%

Recent SEC Filings

Form Type Filed Date Link
424B3 6/26/2026 View on SEC
8-K 6/26/2026 View on SEC
424B3 5/29/2026 View on SEC
8-K 5/29/2026 View on SEC
424B3 5/15/2026 View on SEC
10-Q 5/15/2026 View on SEC
424B3 5/1/2026 View on SEC
8-K 5/1/2026 View on SEC
424B3 5/1/2026 View on SEC
10-K/A 4/30/2026 View on SEC

Company Information

Field Value
Ticker CEROW
Company Name CERO THERAPEUTICS HOLDINGS, INC.
CIK 1870404
Sector Biological Products, (No Diagnostic Substances)
Industry
Emerging growth company
Exchange OTC
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 650-407-2376